We Need Your Urgent Help To Sustain This Website And All Our Research And Community Initiatives. Please Help By Donating To Our Cause. Go To The Sponsorship Section.

BREAKING NEWS
Source: Thailand News  Oct 25, 2020  1 year ago
Thailand News: Various private and public hospitals across Thailand are reporting that there is an increasing number of cases of pediatric infections with the RSV virus or Respiratory Syncytial Virus that tends to affect young children and infants very severely with many such cases now in ICU.   Respiratory syncytial virus, also called human respiratory syncytial virus and Human orthopneumo...
Source: Latest Coronavirus News  Oct 25, 2020  1 year ago
Latest Coronavirus News: Chinese health authorities are reporting new COVID-19 cases sprouting all over in various cities and counties in the far-western region of Xinjiang.   The outbreak initially started in the predominantly muslim Shufu county where a single case was reported on Saturday but in the last few hours hundreds of cases are being reported all over the Xinjiang province. ...
Source: SARS-CoV-2 Strains  Oct 25, 2020  1 year ago
SARS-CoV-2 Strains: A new study led by researchers from University of Missouri along with scientists from University of Nebraska and Karolinska Institute-Sweden have alarmingly discovered that most of the new prevailing SARS-CoV-2 coronavirus strains in the United States and Europe are not just strains containing the D61G mutation on them but they also have two other mutations on them ie P323L and...
Source: COVID-19 Supplements  Oct 25, 2020  1 year ago
COVID-19 Supplements: There is now growing interests in the usage of lysine as a possible adjuvant to treat COVID-19 among the research community after a non-medical professional by the name of Bo Karlicki from the the Dominican Republic took his own initiative to do his own research and started advocating the usage of Lysine to help in the possible treatment of COVID-19 and also as a possibl...
Source: COVID-19 Symptoms  Oct 25, 2020  1 year ago
COVID-19 Symptoms: Researchers from ULB Neuroscience Institute, Université libre de Bruxelles (ULB)-Belgium in a new study have discovered that smell loss in COVID-19 patients is not due to SARS-CoV-2 neuro-invasiveness but rather due to changes in the brain metabolic processes.   This however does not discount than SARS-CoV-2 neuro-invasiveness cannot or does not occur. It does but ...
Source: Aspirin-COVID-19  Oct 24, 2020  1 year ago
Aspirin-COVID-19: A new study led by researchers from University of Maryland School of Medicine (UMSOM) shows that hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin.   Importantly, aspirin takers were less likely to be placed...
Source: POST COVID  Oct 24, 2020  1 year ago
POST COVID: A new study by researchers from Imperial College London-UK, University of Southampton-UK, University of Cambridge-UK and King’s College London-UK and University of Chicago-USA has reported concerning findings showing that patients who had recovered from COVID-19 exhibited significant cognitive deficits.   Numerous past studies have revealed neurological problems in severel...
Source: United States-COVID-19  Oct 24, 2020  1 year ago
United States-COVID-19: America reported a record of more than 81,000 new COVID-19 infections over the last 24 hours according to figures from Worldometer.   It was reported that between 8:30 pm Thursday and the same time Friday, 81,210 infections were recorded, bringing the total number since the start of the pandemic to nearly 8.5 million COVID-19 infected cases in the country w...
Source: COVID-19 Supplements  Oct 24, 2020  1 year ago
COVID-19 Supplements: A new study by researchers from the Institute for Optimum Nutrition-UK, University of Otago-New Zealand, Swansea University Medical School-UK, Morriston Hospital-UK Eastern, Virginia Medical School-USA and University of Oxford-UK demonstrates that Vitamin C can be used as an adjuvant to treat COVID-19 especially in the severe and critical stages.   Ascorbic acid or vit...
Source: COVID-19 -Dexamethasone  Oct 24, 2020  1 year ago
COVID-19 -Dexamethasone: A new study led by researchers from University of Virginia-U.S. along with scientist from Polish Academy of Sciences-Poland, Poznan University of Technology-Poland, Medical University of Bialystok-Poland and University of South Carolina-U.S. has discovered a about how the human body transports dexamethasone, a drug that can increase the survival chances of patients wi...
Source: Convalescent Plasma  Oct 23, 2020  1 year ago
Convalescent Plasma: An open label phase II multicenter randomized controlled trial (PLACID Trial) of convalescent plasma in the management of moderate COVID-19 in 464 adults in India has showed that the treatment protocol does not does not reduce their chances of getting seriously ill or dying, in simple words, it is not effective in treating COVID-19.   The study findings were publis...
Source: COVID-19 Infections  Oct 23, 2020  1 year ago
Editorial:   COVID-19 Infections: A new record high of 478,065 COVID-19 infections was recorded in the last 24 hours with just a mere 6,740 deaths. (Source: Worldometer)   However despite the mediocre death rates, the rising new COVID-19 infections are a good sign as it shows that the second wave is truly coming and more are expected to die.   Now some might wonder as to why a med...
Source: COVID-19 Updates  Oct 23, 2020  1 year ago
COVID-19 Updates: A new study by researchers from Massachusetts General Hospital, Icahn School of Medicine, Cohen Children's Medical Center, University of California-San Francisco, Hutchinson Cancer Research Center, University of Pennsylvania and Zucker School of Medicine at Hofstra-Northwell, Hempstead has shown that contrary what was earlier assumed, may severe COVID-19  patients do not...
Source: America Latest  Oct 23, 2020  1 year ago
America Latest: America is facing a major health crisis with the Trump Administration in power and the degree of incompetency, greed and corruption in play. Already America has a total of more than 8.4 million confirmed COVID-19 cases with realistic figures expected to be much higher due to under-reporting in Republican controlled states and lack of testing among asymptomatic cases and as of today...
Source: Virus News  Oct 23, 2020  1 year ago
Virus News: Alarmingly three documented case studies have emerged of individuals developing Parkinson's-like symptoms in the weeks following infection with SARS-CoV-2, the virus that causes COVID-19.   Initially thought to be rare, there are now growing cases being reported by clinicians in Italy, UK, Germany and United States with more researchers and physicians paying more a...
Sourec: COVID-19 News  Oct 22, 2020  1 year ago
COVID-19-News: Researchers from Semmelweis University and Pazmany Peter Catholic University in Budapest-Hungary, in a news study shows and echoes the same hypothesis that Thailand Medical News has been stating since the start of the pandemic: COVID-19 disease progression and severity and even Post-COVID-19 effects are all dictated by the various mutated strains and variants of the SARS-CoV-2 coron...
Source: Drugs-COVID-19  Oct 22, 2020  1 year ago
Drugs-COVID-19: Fortunately another COVID-19 drug scam is being prevented after the remdesivir saga thanks to honest and credible researchers that cannot be manipulated by money. The US FDA under the Trump administration and Trump’s family and cronies has done even damage with hydrochloroquine and remdesivir issues with many American lives lost and hopefully after Trump loses this elections,...
Source: COVID-19 Scams  Oct 22, 2020  1 year ago
COVID-19 Scams: Associate Editor at the British Medical Journal (BMJ) Professor Dr Peter Doshi, in a daring but truthful revelation yesterday warned that vaccine trials currently underway are not designed to tell us if they will save lives. https://www.bmj.com/content/371/bmj.m4037    Although several COVID-19 vaccine trials are now in their most advanced phase 3 stage, but what will i...
Source: Vaccine News  Oct 22, 2020  1 year ago
Vaccine News:  Brazil's health authority Anvisa reported that Brazilian volunteer participating in clinical trials of the COVID-19 vaccine developed by Oxford University and AstraZeneca has died on the 18th of October.   It was unclear whether the volunteer had received the vaccine or a placebo and in countries like Brazil, the organizers can easily switch the facts in or...
Source: Food and Nutrition  Oct 21, 2020  1 year ago
Food-Nutrition: Dutch researchers from University of Twente-Netherlands led by pediatrician Dr Ellen van der Gaag in a news study on the effect of unprocessed, pure food on children's health, specifically on the common cold and other upper respiratory tract infections have also discovered certain foods that can help prevent respiratory tract infections.   The study findings were publish...
Source: COVID-19 Spread  Oct 21, 2020  1 year ago
COVID-19 Spread: Brazilian researchers have developed a new model that   predicts spatial and temporal evolution of epidemic diseases and can help plan more effective social isolation programs with less socio-economic impact. The new research study proposes an epidemiological model that provides a more detailed description of how the SARS-CoV-2 coronavirus that causes the COVID-19 diseas...
Source: Precision Epidemiology   Oct 21, 2020  1 year ago
Precision Epidemiology: Finally more and more researchers are waking up to fact that COVID-19 cannot be treated in a broad spectrum manner as a personalized or precision medicine approach has to be undertaken to treat every individual as there are so many factors at play including the human host genes and variants from one person to the next coupled with fact that even strains of the virus that ar...
Source: COVID-19 Diagnostics  Oct 21, 2020  1 year ago
COVID-19 Diagnostics: Siemens Healthineers has introduced the CLINITEST Rapid COVID-19 Antigen Test that helps identify SARS-CoV-2 infected individuals in 15 minutes so they can isolate sooner and avoid spreading COVID-19. The easy-to-use test, which doesn't require specialized laboratory personnel or instruments, offers flexibility to test in locations that benefit from immediate results &nb...
Source: Antibodies COVID-19  Oct 21, 2020  1 year ago
Antibodies COVID-19: A Canadian study last month led by by Université de Montréal professor Dr Andrés Finzi, holder of a Canada Research Chair in Retroviral Entry, and Dr Renée Bazin, director of innovation at Héma-Québec, showed that the neutralization capacity of antibodies produced by a SARS-CoV-2 infected person declined after six weeks, as the person ...
Source: COVID-19 Updates  Oct 20, 2020  1 year ago
COVID-19 Updates: A breakthrough international research led by scientist from University of Bristol-UK along with experts from University of Queensland –Australia, University of Tartu-Estonia, University of Zurich-Switzerland, Biological Research Centre (BRC), Szeged-Hungary, University of Helsinki-Finland, Institute of Biochemistry-Switzerland, University of Liverpool-UK and Singapore Immun...
Source: Canada COVID-19 Updates  Oct 20, 2020  1 year ago
Canada COVID-19 Updates: A more aggressive second wave of COVID-19 has hit Canada with total infected cases now topping over 200,000 COVID-19 cases and is nearing  to 10,000 deaths according to official COVID-19 data compiled by Canadian broadcasters CBC and CTV.   What is also more concerning is that a few of the SARS-CoV-2 antibody resistant strains and also more aggressive and infec...
Source: COVID-19 Clinical Care  Oct 20, 2020  1 year ago
COVID-19 Clinical Care: Researchers from the department of Genetics, University of Georgia-U.S. and Shanghai Jiao Tong University School of Medicine, Shanghai-China in a collaborative study have discovered a correlation between the white blood cell count and COVID-19 disease severity. The white blood cells are a critical component of the body’s immune system that helps fight infections. &n...
Source: COVID-19 Drugs  Oct 20, 2020  1 year ago
COVID-19 Drugs: Ensifentrine a drug originally developed by UK based pharmaceutical cum biotech company Verona Pharma to treat chronic obstructive pulmonary disease or COPD could be a new treatment option for hospitalized COVID-19 patients. According to research this dual bronchodilator and anti-inflammatory drug be safe and effective in COVID-19 patients experiencing the debilitating effects of s...
Source: U.S. COVID-19   Oct 20, 2020  1 year ago
U.S. COVID-19 Updates: America is facing a new surge in COVID-19 cases and the coming winter season will see a catastrophic scenario never seen in its history where it is projected that millions more of Americans will contract the SARS-CoV-2 while hundreds of thousands will be severely ill and will ultimately die.   To date more than 220,180 Americans had died from the COVID-19 disease whil...
Source: Post COVID-19  Oct 20, 2020  1 year ago
Post COVID-19: Researchers from University of Oxford in a new study looking at the longer-term impact of COVID-19 has found that a large proportion of COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus.   The study team carrying out the C-MORE study has also detected a...
Source: Research News  Oct 20, 2020  1 year ago
Research News: A study team from the Scripps Research Institute, La Jolla-California led by Dr Taishi Kimura, Ph.D., postdoctoral research associate and first author of the study has uncovered an important disease-fighting role for cells called hepatocytes, which constitute most of the liver. It was found that hepatocytes help control infections from common viruses called coxsackieviruses, and pro...
Source: HIV News  Oct 19, 2020  1 year ago
HIV News: University of British Columbia researchers have concluded a new study of which the findings are set to change international treatment recommendations for individuals who are newly diagnosed with HIV, an update that could affect nearly two million people per year worldwide.   The research found that the antiviral dolutegravir is the optimal medication for first-line treatment for i...
Source: COVID-19 Questions  Oct 19, 2020  1 year ago
COVID-19 Questions: In the last few days as we were perusing more studies and emerging data, some things really are not adding up and perhaps some other media, researchers or experts can help us with a few answers please.   First, a study dated 2008 makes mention of SARS-CoV-2 and even of a SARS-CoV-3 and this study though was conducted by Chinese researchers in Beijing was catalogued by th...
Source: NEURO-COVID  Oct 19, 2020  1 year ago
NEURO-COVID: A new study led by researchers from New York University Langone Health/NYU School of Medicine along with scientists from John Hopkins and University of Utah have found that about one in seven COVID-19 patients has potentially damaging neurological injuries.   It was found that these neurological injuries range from temporary confusion resulting from low body-oxygen levels ...
Source: COVID-19 News  Oct 19, 2020  1 year ago
COVID-19-News: Researchers from IBM Research at T.J. Watson Research Center-New York, have in a new study found that heteroplasmy was more common in COVID-19 patients that actually thought. Heteroplasmy is a condition when a COVID-19 patient is co-infected with more than one variant or lineage of the SARS-CoV-2 coronavirus. The implications from this study finding are massive in terms of treatment...
Source: COVID-19 Research  Oct 19, 2020  1 year ago
COVID-19 Research: A new study by researchers from John Hopkins involving young obese mice has found that obesity typically leads to upregulation of ACE2 receptor expression especially in the lungs and trachea, increasing the risk factor for SARS-CoV-2 infection and severity.   In the study, the researchers demonstrated that:   -a) Ace2 expression is elevated in the lung and trach...
Source: Virus News  Oct 18, 2020  1 year ago
Virus News: A frequent medical question since the last century has been why are some individuals more resilient to viruses than others? Possible answers to that question has eluded researchers and scientists for centuries and, in the age of COVID-19, has come to represent one of the holy grails of biomedical research.   Dr Ed Chuong, an assistant professor of molecular, cellular and develop...
Source: Antibodies-COVID-19  Oct 18, 2020  1 year ago
Antibodies-COVID-19: A new unbiased study by researchers from the University of Montreal has shown that antibody levels drop rapidly in recovering COVID-19 patients.   The study team performed repeated analyses at 1-month intervals on 31 convalescent individuals to evaluate how the humoral responses against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike glycoprotein,...
Source: COVID-19 Latest  Oct 18, 2020  1 year ago
COVID-19 Latest: Researchers from John Hopkins have identified a compound known as factor D Inhibitor(ACH-145951) that can inhibit the alternative complement immune pathway system that is activated by the SARS-CoV-2 spike protein. Blocking this immune system pathway may stop COVID-19 Infection and prevent severe organ damage.   Animal models demonstrating end-organ protection in C...
Source: COVID-19 News  Oct 18, 2020  1 year ago
COVID-19 News: Researchers from University of Pittsburgh, Cedars-Sinai Medical Center-Los Angeles and Martin Luther University Halle-Wittenberg-Germany have in a new study discovered that a mutation strain of the SAR-CoV-2 called D839Y/N/E that has a unique superantigenic insert in the spike region and is able to generate a hyperinflammatory syndrome reminiscent of toxic shock syndrome (TSS)&...
Source: COVID-19-Infants  Oct 17, 2020  1 year ago
COVID-19-Infants: French researchers from the Division of Pediatrics and Neonatal Critical Care at “A.Béclère” Medical Centre, Paris Saclay University Hospitals have in a new meta-analysis study involving 176 case reports and past studies found that up to 30 percent of all COVID-19 infected infants had contracted the virus from their mothers.   The study was publis...
Source: Mutations -COVID-19  Oct 17, 2020  1 year ago
Mutations -COVID-19: Biologist and genomic experts from Duke University have identified a number of "silent" mutations in the roughly 30,000 letters of the virus's genetic code that helped it thrive once it made the leap to humans and possibly helped set the stage for the global pandemic. The subtle changes involved how the virus folded its RNA molecules within human cells....
Source: COVID-19 Trends  Oct 17, 2020  1 year ago
COVID-19 Trends: In the beginning of the pandemic we had a lot of so called non-medical academics and government authorities trying to show off their prowess and ways that the pandemic ‘could be stopped ‘and their theories of flattening the curve with a variety for techniques such as social distancing of only between 1 to 3 meters, etc without first understanding a thing about the viru...
Source: Thailand Medical News  Oct 16, 2020  1 year ago
Thailand News: Local Thai media are reporting that this evening thousands of unarmed Thai protesters who have been peacefully protesting against the Thai government near a shopping district in Bangkok are being sprayed upon with a solution of tear gas or unknown chemicals that has been imported from America and mixed with water and blue paint and God knows what other chemicals. https://www.thairat...
Source: Vaccine-COVID-19  Oct 16, 2020  1 year ago
Vaccine-COVID-19: As more studies are showing that antibodies will ultimately only provide short term optimal protection of anything between 10 to 16 weeks and while at the same time other studies are also showing that many AAV (Adeno Associated Virus) vector RNA vaccines that are currently being developed and are in phase 3 trials might actually cause certain adverse effects https://www.thailandm...
Source: Remdesivir  Oct 16, 2020  1 year ago
Remdesivir:  Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.   The study results of the trial are under review for publi...
Source: COVID-19 Winter  Oct 16, 2020  1 year ago
COVID-19 Winter: Researchers from the University of Utah in a new study has shown that individual particles of SARS-CoV-2 coronavirus undergo structural destabilization at relatively mild but elevated temperatures, strengthening the case for the COVID-19 resurgence in the coming winter.   The research findings are published on a preprint server and are currently being peer-reviewed. https:/...
Source: COVID-19 Research  Oct 16, 2020  1 year ago
COVID-19 Research: A new international comparison study of the various coronaviruses and their effects on human host proteins and various human cellular pathways have revealed among many findings that the SARS-CoV-2 coronavirus protein Orf9b actually binds with the human host mitochondria protein TOM 70.   Orf9b of SARS-CoV-2 was found to be localized to mitochondria upon overexpression as ...
Source: Vaccine News  Oct 16, 2020  1 year ago
Vaccine News: Russia announced two months ago that its AAV (Adeno-associated virus) vector was approved for use despite lacking proper supporting study data and a proper phase 3 trial. In reality to date, the Sputnik V vaccine has been a flop as despite the Russian health authorities not admitting it, local Russian physicians and hospitals reported that  that many vaccinated candidates not on...
Source: COVID-19 Crisis  Oct 16, 2020  1 year ago
COVID-19 Crisis: The current COVID-19 pandemic so far has been just a small speck compared of what is really to come and already sadly we can see the stupidity and incompetency of most governments and health agencies so far in terms of how the crisis has been handled in most European countries and the Americas( North and South America)   As of the 16th of October 2020, officially we have mo...
Source: Influenza 2020/2021  Oct 15, 2020  1 year ago
Influenza 2020/2021: Two different studies one by Chinese researchers and another led by British scientists show the high risk involved with sequential infection of influenza followed by COVID-19.   In the first study by Chinese scientist from State Key Laboratory of Virology, College of Life Sciences, Wuhan University-Wuhan, team shows that infection with the Influenza A virus or IAV actua...
Source: COVID-19 Neutralizing Antibodies   Oct 15, 2020  1 year ago
COVID-19 Neutralizing Antibodies: A new study by researchers and immunologists from Westlake University, Zhejiang-China, Tsinghua University, Beijing-China and Southern University of Science and Technology, Shenzhen-China has found that human bivalent anti-spike antibodies are more effective in terms of viral neutralization and controlling a SARS-CoV-2 infection in humans.   The study team ...
Source: Antibodies  Oct 15, 2020  1 year ago
Antibodies, Antibody test and ADE are a few words that has been in many news articles in the last few months as a result of the ongoing COVID-19 pandemic but many people still do not really have a proper perspective about what they are properly, hence we created this guide with the hope that it might help some of our readers. The summarized guide is not in detailed but just enough for individuals ...
Source: COVID-19 Intranasal Drugs  Oct 15, 2020  1 year ago
COVID-19 Intranasal Drugs: North Carolina based clinical-stage biotechnology company Novan, Inc. that specializes in various nitric oxide based therapeutics has announced that its vitro studies involving its NITRICIL™ platform technology that uses berdazimer sodium has demonstrated antiviral effects against the SARS-CoV-2 coronavirus tha causes the COVID-19 disease.   Berdaz...
Source:Airborne SARS-CoV-2   Oct 15, 2020  1 year ago
Airborne SARS-CoV-2 virus can be detected by using dehumidifiers according to a new study by researchers from Maryland University.   The study team presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 virus in the atmosphere at any location.   The study findings are published on a preprint server and are currently being peer reviewed. ...

MOST READ

Feb 05, 2020  2 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  1 year ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  1 year ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  1 year ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  2 years ago
Source: Myocardial Injury
Jun 09, 2020  2 years ago
Source: COVID-19 News
May 21, 2020  2 years ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  2 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  2 years ago
Source : Thailand Medical News
Feb 11, 2020  2 years ago